Loading blog post…
A complete guide to laser and IPL treatment of vascular lesions — how selective photothermolysis targets oxyhemoglobin in blood vessels, the pulsed dye laser (PDL 595 nm) for port wine stains and facial telangiectasia, KTP 532 nm for superficial capillaries and rosacea redness, Nd:YAG 1064 nm for deeper leg veins and recalcitrant vessels, IPL for diffuse facial redness, cherry angioma treatment, the purpura reaction from PDL, and realistic expectations by lesion type.
· By MedSpot Editorial · 6 min read
Vascular lesion treatment with laser and intense pulsed light (IPL) uses selective photothermolysis — targeting the chromophore oxyhemoglobin within abnormal blood vessels — to heat and close unwanted vasculature while leaving surrounding skin intact. Different lasers and wavelengths target different vascular lesions based on vessel depth, diameter, and chromophore concentration. Here is a complete guide.
Anderson and Parrish (1983) established the principle of selective photothermolysis: a laser wavelength absorbed preferentially by a specific chromophore, with a pulse duration shorter than the thermal relaxation time of the target, selectively heats and destroys the target while sparing surrounding tissue.
For vascular lesions, the chromophore is oxyhemoglobin — the oxygen-carrying form of hemoglobin in blood. Oxyhemoglobin has absorption peaks at:
When laser energy at these wavelengths is absorbed by oxyhemoglobin:
The PDL is the gold standard for vascular lesion treatment — designed specifically for oxyhemoglobin absorption at 577/595 nm (the Q-switched iteration improved from the original 577 nm to 595 nm for deeper penetration).
Mechanism: 595 nm is strongly absorbed by oxyhemoglobin; pulse durations of 0.45–40 ms allow selective thermal damage to vessels of varying diameters.
Best for:
The purpura reaction: At standard PDL settings, the rapid thermal damage to blood vessels produces immediate purpura — a bruise-like redness that turns purple within minutes, representing blood extravasation from thermally damaged capillary walls. Purpura resolves in 7–14 days. Sub-purpuric settings (lower fluence, longer pulse duration) can minimize purpura with reduced efficacy per session; multiple sessions at sub-purpuric settings vs. fewer sessions at purpuric settings is a clinical tradeoff.
The KTP (potassium titanyl phosphate) laser at 532 nm also has strong oxyhemoglobin absorption — slightly less than 577/595 nm but in the same spectral territory.
Best for:
Advantage over PDL: The 532 nm KTP tends to produce less purpura than PDL at equivalent efficacy for superficial vessels — more socially acceptable immediate downtime for many patients.
Disadvantage: Shallower penetration than PDL — less effective for deeper or larger caliber vessels.
Long-pulse Nd:YAG at 1064 nm has weaker oxyhemoglobin absorption than the 500–600 nm range but significantly deeper tissue penetration (6–8 mm vs. 1–2 mm for KTP).
Best for:
Safe for darker skin types: 1064 nm has relatively less melanin absorption — safer for Fitzpatrick types IV–VI compared to KTP and PDL.
IPL is not a single-wavelength laser but a broadband light source filtered to selected wavelength ranges. For vascular treatment, filters selecting 515–600 nm or 560–600 nm target oxyhemoglobin.
Best for:
Limitations: IPL is not appropriate for port wine stains, hemangiomas, or significant individual vessels where precise wavelength and pulse targeting are needed. More operator-dependent than single-wavelength lasers.
Cherry angiomas (senile angiomas, de Morgan spots) are benign vascular proliferations — bright red, dome-shaped papules 1–5 mm, appearing from the 30s onward. They contain a dense nest of dilated capillaries.
Treatment: KTP 532 nm or PDL are both highly effective — typically 1–2 sessions for complete clearance. Electrocautery (simple, inexpensive, immediate) is an alternative for very small lesions. No recurrence of the treated lesion; new cherry angiomas may continue to appear elsewhere.
Superficial red and blue leg veins 0.1–1.5 mm diameter. Treatment options:
The fine red vessels visible on the nose, cheeks, and nasal ala — most commonly from rosacea, sun damage, or hereditary predisposition.
Treatment: KTP 532 nm or PDL; 1–3 sessions; IPL for diffuse cases. Individual discrete vessels are targeted and immediately blanch during treatment.
During treatment: Mild stinging or rubber-band-snap sensation at each pulse. Topical anesthetic reduces discomfort; most patients rate 2–4/10.
Post-treatment (no purpura settings): Immediate redness and mild swelling at treated vessels; resolves within hours. Makeup applicable same day.
Post-treatment (purpuric PDL settings): Immediate purpura (blue-purple bruising) at treated areas — inevitable at standard PDL settings. Resolves in 7–14 days. Concealer covers adequately after Day 2.
Results timeline: Treated vessels gradually fade over 2–6 weeks as the body clears the coagulated vasculature.
| Wavelength | Fitzpatrick I–III | Fitzpatrick IV | Fitzpatrick V–VI |
|---|---|---|---|
| PDL 595 nm | Excellent | Caution (melanin competition) | High risk — avoid |
| KTP 532 nm | Excellent | Caution | Avoid |
| Nd:YAG 1064 nm | Good | Good | Appropriate (less melanin absorption) |
| IPL | Excellent | Caution | Avoid |
For Fitzpatrick types IV–VI with vascular lesions, Nd:YAG 1064 nm is the laser of choice — its longer wavelength has significantly less epidermal melanin absorption, reducing the risk of post-treatment hyperpigmentation or burns.
Looking for a vascular lesion or laser treatment provider? Browse med spa providers on MedSpot →